160 related articles for article (PubMed ID: 33277754)
1. Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.
Huang Y; Tsubota S; Nishio N; Takahashi Y; Kadomatsu K
Cancer Sci; 2021 Feb; 112(2):715-724. PubMed ID: 33277754
[TBL] [Abstract][Full Text] [Related]
2. A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
van Groningen T; Akogul N; Westerhout EM; Chan A; Hasselt NE; Zwijnenburg DA; Broekmans M; Stroeken P; Haneveld F; Hooijer GKJ; Savci-Heijink CD; Lakeman A; Volckmann R; van Sluis P; Valentijn LJ; Koster J; Versteeg R; van Nes J
Nat Commun; 2019 Apr; 10(1):1530. PubMed ID: 30948783
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
Pediatr Blood Cancer; 2024 Jan; 71(1):e30735. PubMed ID: 37859597
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Sep; ():. PubMed ID: 37693610
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Westerhout EM; Hamdi M; Stroeken P; Nowakowska NE; Lakeman A; van Arkel J; Hasselt NE; Bleijlevens B; Akogul N; Haneveld F; Chan A; van Sluis P; Zwijnenburg D; Volckmann R; van Noesel CJM; Adameyko I; van Groningen T; Koster J; Valentijn LJ; van Nes J; Versteeg R
Cancer Res; 2022 Feb; 82(3):484-496. PubMed ID: 34853072
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.
Yu EY; Zahid SS; Aloe S; Falck-Pedersen E; Zhou XK; Cheung NV; Lue NF
Commun Biol; 2021 Nov; 4(1):1315. PubMed ID: 34799676
[TBL] [Abstract][Full Text] [Related]
7. T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.
Kaufman ME; Vayani OR; Moore K; Chlenski A; Wu T; Chavez G; Lee SM; Desai AV; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Jun; ():. PubMed ID: 37425883
[TBL] [Abstract][Full Text] [Related]
8. Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.
Jahangiri L; Pucci P; Ishola T; Pereira J; Cavanagh ML; Turner SD
Discov Oncol; 2021 Nov; 12(1):56. PubMed ID: 35201514
[TBL] [Abstract][Full Text] [Related]
9. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
[TBL] [Abstract][Full Text] [Related]
10. Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism.
Kimura S; Sekiguchi M; Watanabe K; Hiwatarai M; Seki M; Yoshida K; Isobe T; Shiozawa Y; Suzuki H; Hoshino N; Hayashi Y; Oka A; Miyano S; Ogawa S; Takita J
PLoS One; 2021; 16(1):e0245526. PubMed ID: 33465163
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma is composed of two super-enhancer-associated differentiation states.
van Groningen T; Koster J; Valentijn LJ; Zwijnenburg DA; Akogul N; Hasselt NE; Broekmans M; Haneveld F; Nowakowska NE; Bras J; van Noesel CJM; Jongejan A; van Kampen AH; Koster L; Baas F; van Dijk-Kerkhoven L; Huizer-Smit M; Lecca MC; Chan A; Lakeman A; Molenaar P; Volckmann R; Westerhout EM; Hamdi M; van Sluis PG; Ebus ME; Molenaar JJ; Tytgat GA; Westerman BA; van Nes J; Versteeg R
Nat Genet; 2017 Aug; 49(8):1261-1266. PubMed ID: 28650485
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel.
van Wezel EM; van Zogchel LMJ; van Wijk J; Timmerman I; Vo NK; Zappeij-Kannegieter L; deCarolis B; Simon T; van Noesel MM; Molenaar JJ; van Groningen T; Versteeg R; Caron HN; van der Schoot CE; Koster J; van Nes J; Tytgat GAM
JCO Precis Oncol; 2019; 3():. PubMed ID: 34036221
[TBL] [Abstract][Full Text] [Related]
13. Effects of epidermal growth factor on the [3H]-thymidine uptake in the SK-N-SH and SH-SY5Y human neuroblastoma cell lines.
da Motta LA; Galli P; Piva F; Maggi R
Arq Neuropsiquiatr; 1997 Sep; 55(3A):444-51. PubMed ID: 9629363
[TBL] [Abstract][Full Text] [Related]
14. Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity.
D'Amico S; Tempora P; Gragera P; Król K; Melaiu O; De Ioris MA; Locatelli F; Fruci D
Front Immunol; 2023; 14():1268645. PubMed ID: 37849756
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells.
Leventhal PS; Randolph AE; Vesbit TE; Schenone A; Windebank A; Feldman EL
Exp Cell Res; 1995 Nov; 221(1):179-86. PubMed ID: 7589243
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
[TBL] [Abstract][Full Text] [Related]
17. Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.
Afanasyeva EA; Gartlgruber M; Ryl T; Decaesteker B; Denecker G; Mönke G; Toprak UH; Florez A; Torkov A; Dreidax D; Herrmann C; Okonechnikov K; Ek S; Sharma AK; Sagulenko V; Speleman F; Henrich KO; Westermann F
Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33658318
[TBL] [Abstract][Full Text] [Related]
18. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
20. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.
Yshii LM; Denadai-Souza A; Vasconcelos AR; Avellar MC; Scavone C
J Neuroinflammation; 2015 Oct; 12():193. PubMed ID: 26502720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
